ASCENSION ST. VINCENTS RIVERSIDE — History
CCN 100040 | 3-year financial timeline | COVID resilience: 29/100
🛡️ Public data only — no PHI permitted on this instance.
$450M
Latest Revenue (FY2022)
-3.4%
Revenue CAGR (3yr)
-5.0%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $481M | $481M | $450M | -6.6% | -3.4% |
| Operating Expenses | $486M | $518M | $472M | -8.8% | -1.5% |
| Operating Margin | -1.0% | -7.6% | -5.0% | +34.0% | +0.0% |
| Net Income | $-5M | $-36M | $-22M | +38.4% | +0.0% |
| Licensed Beds | 420 | 453 | 362 | -20.1% | -7.2% |
| Total Patient Days | 98,369 | 95,966 | 78,755 | -17.9% | -10.5% |
| Medicare Day % | 28% | 25% | 25% | +1.0% | -6.0% |
| Medicaid Day % | 5% | 5% | 2% | -47.4% | -31.9% |
COVID Impact & Recovery
Resilience Score: 29/100 — Distressed — significant COVID damage
Revenue recovery from FY2020 to FY2022: -6.6% ($481M → $450M)
FY2020 captured the initial COVID shock. Slow recovery suggests structural challenges beyond COVID.
Trend Summary
Revenue▼ Declining
Operating Margin▼ Declining
Beds▼ Declining
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
-3.4%
This Hospital
+7.6%
State Avg
Latest Margin
-5.0%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $434M | -7.0% |
| FY2024 (proj) | $418M | -9.0% |
| FY2025 (proj) | $402M | -11.0% |